253 related articles for article (PubMed ID: 25743023)
41. Aggressive CD5-positive B-cell lymphoma after remission of CD5-negative follicular lymphoma with distinct immunoglobulin heavy chain rearrangement and translocation.
Sonoki T; Ishihara S; Uneda S; Hanaoka N; Kurimoto M; Matsuoka H; Nakakuma H
Int J Hematol; 2008 Oct; 88(3):299-303. PubMed ID: 18758895
[TBL] [Abstract][Full Text] [Related]
42. Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunophenotypic, and molecular features.
Mirza I; Macpherson N; Paproski S; Gascoyne RD; Yang B; Finn WG; Hsi ED
J Clin Oncol; 2002 Feb; 20(3):647-55. PubMed ID: 11821444
[TBL] [Abstract][Full Text] [Related]
43. Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma.
Xie X; Sundram U; Natkunam Y; Kohler S; Hoppe RT; Kim YH; Cook JR; Hammel J; Swerdlow SH; Guitart J; Smith MD; Bosler D; Listinsky C; Lossos IS; Hsi ED
Mod Pathol; 2008 Jun; 21(6):653-9. PubMed ID: 18264083
[TBL] [Abstract][Full Text] [Related]
44. CD5+ T-cell/histiocyte-rich large B-cell lymphoma.
Chang CC; Bunyi-Teopengco E; Eshoa C; Chitambar CR; Kampalath B
Mod Pathol; 2002 Oct; 15(10):1051-7. PubMed ID: 12379751
[TBL] [Abstract][Full Text] [Related]
45. IRF8 is associated with germinal center B-cell-like type of diffuse large B-cell lymphoma and exceptionally involved in translocation t(14;16)(q32.33;q24.1).
Tinguely M; Thies S; Frigerio S; Reineke T; Korol D; Zimmermann DR
Leuk Lymphoma; 2014 Jan; 55(1):136-42. PubMed ID: 23573829
[TBL] [Abstract][Full Text] [Related]
46. Fluorescence in situ hybridization detection of chromosome IGH/BCL2 translocations from paraffin-embedded tissue: evaluation in follicular lymphoma.
Hirose Y; Masaki Y; Ozaki M
Int J Hematol; 2003 Aug; 78(2):154-9. PubMed ID: 12953811
[TBL] [Abstract][Full Text] [Related]
47. Diffuse large B cell lymphoma derived from nodular lymphocyte predominant Hodgkin lymphoma presents with variable histopathology.
Hartmann S; Eray M; Döring C; Lehtinen T; Brunnberg U; Kujala P; Vornanen M; Hansmann ML
BMC Cancer; 2014 May; 14():332. PubMed ID: 24885870
[TBL] [Abstract][Full Text] [Related]
48. [Pathologic characteristics of bone marrow for
CD5 positive small B cell lymphoma].
Peng S; Zhu F; You S; Gong M; Wen Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Apr; 41(4):374-9. PubMed ID: 27241147
[TBL] [Abstract][Full Text] [Related]
49. Large cell variants of CD5+, CD23- B-cell lymphoma/leukemia.
Dunphy CH; Perkins SL
Arch Pathol Lab Med; 2001 Apr; 125(4):513-8. PubMed ID: 11260626
[TBL] [Abstract][Full Text] [Related]
50. Primary hepatosplenic CD5-positive diffuse large B-cell lymphoma: a case report with literature review.
Zhang X; Sun M; Zhang L; Shao H
Int J Clin Exp Pathol; 2013; 6(5):985-9. PubMed ID: 23638236
[TBL] [Abstract][Full Text] [Related]
51. CD5+ follicle center lymphoma. Immunophenotyping detects a unique subset of "floral" follicular lymphoma.
Tiesinga JJ; Wu CD; Inghirami G
Am J Clin Pathol; 2000 Dec; 114(6):912-21. PubMed ID: 11338480
[TBL] [Abstract][Full Text] [Related]
52. Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas.
Tsuyama N; Ennishi D; Yokoyama M; Baba S; Asaka R; Mishima Y; Terui Y; Hatake K; Takeuchi K
Oncotarget; 2017 May; 8(20):33487-33500. PubMed ID: 28380441
[TBL] [Abstract][Full Text] [Related]
53. Signet-ring cell lymphoma: clinicopathologic, immunohistochemical, and fluorescence in situ hybridization studies of 7 cases.
Zhang S; Sun J; Fang Y; Nassiri M; Liu L; Zhou J; Stohler R; Choi H; Vance GH
Ann Diagn Pathol; 2017 Feb; 26():38-42. PubMed ID: 28038709
[TBL] [Abstract][Full Text] [Related]
54. CD5 expression correlates with inferior survival and enhances the negative effect of p53 overexpression in diffuse large B-cell lymphoma.
Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Meng B; Zhang H
Hematol Oncol; 2019 Oct; 37(4):360-367. PubMed ID: 31359442
[TBL] [Abstract][Full Text] [Related]
55. B-cell lymphomas with coexpression of CD5 and CD10.
Dong HY; Gorczyca W; Liu Z; Tsang P; Wu CD; Cohen P; Weisberger J
Am J Clin Pathol; 2003 Feb; 119(2):218-30. PubMed ID: 12579992
[TBL] [Abstract][Full Text] [Related]
56. [Primary gastrointestinal diffuse large B-cell lymphoma: an immunohistochemical and prognostic study of 90 cases].
Lin L; Min M; Bi CF; Wang XQ; Luo TY; Zhao S; Zhang WY; Liu WP
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):220-6. PubMed ID: 21615994
[TBL] [Abstract][Full Text] [Related]
57. Pattern of CD14+ follicular dendritic cells and PD1+ T cells independently predicts time to transformation in follicular lymphoma.
Smeltzer JP; Jones JM; Ziesmer SC; Grote DM; Xiu B; Ristow KM; Yang ZZ; Nowakowski GS; Feldman AL; Cerhan JR; Novak AJ; Ansell SM
Clin Cancer Res; 2014 Jun; 20(11):2862-72. PubMed ID: 24727328
[TBL] [Abstract][Full Text] [Related]
58. Clinicopathologic Features and Genomic Signature of De Novo CD5 + Diffuse Large B-Cell Lymphoma : A Multicenter Collaborative Study.
Sang W; Ma Y; Wang X; Ma Y; Shen Z; Gu W; Wang F; Ye J; Zhang C; Miao Y; Xu C; Liu Q; Li B; Tu J; Wang C; Shi Y; Sun S; Yan D; Song X; Sun C; Shao Y; Xu L; Li Z; Ma D; Xu K; Young KH; Liu H
Am J Surg Pathol; 2022 Nov; 46(11):1533-1544. PubMed ID: 36006771
[TBL] [Abstract][Full Text] [Related]
59. Coexpression of CD5 and CD43 predicts worse prognosis in diffuse large B-cell lymphoma.
Ma XB; Zhong YP; Zheng Y; Jiang J; Wang YP
Cancer Med; 2018 Sep; 7(9):4284-4295. PubMed ID: 30019388
[TBL] [Abstract][Full Text] [Related]
60. Pure intravascular recurrence of CD5-positive diffuse large B-cell lymphoma primarily arising from the nasal cavities.
Kano R; Masaie H; Hino A; Yasuoka H; Nagata S; Ishikawa J; Nakatsuka SI
Diagn Pathol; 2018 Jul; 13(1):46. PubMed ID: 30041681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
